Copenhagen, Denmark

Margit Haahr Hansen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Margit Haahr Hansen: Innovator in Antibody Technology

Introduction

Margit Haahr Hansen is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant polyclonal antibodies. With a total of 2 patents, her work is paving the way for advancements in therapeutic methods.

Latest Patents

One of her latest patents is titled "Anti-orthopoxvirus recombinant polyclonal antibody." This invention discloses an anti-orthopoxvirus recombinant polyclonal antibody that comprises distinct members capable of binding at least three orthopoxvirus-related antigens. The patent also includes a pharmaceutical composition comprising the antibody and a method for its production. Additionally, it describes a polyclonal cell line capable of producing the recombinant polyclonal antibody, along with therapeutic methods utilizing this antibody.

Another significant patent is "Method for linking sequences of interest." This invention presents a multiplex overlap-extension RT-PCR method that efficiently links two or more nucleotide sequences encoding domains or subunits of a heteromeric protein in a single reaction. This method simplifies the linkage of variable region encoding sequences from immunoglobulins, T cell receptors, or B cell receptors, allowing for the generation of libraries of variable region encoding sequences in a high-throughput format.

Career Highlights

Margit Haahr Hansen is currently associated with Symphogen A/S, where she continues to innovate in the field of antibody technology. Her work has been instrumental in advancing therapeutic applications that can significantly impact healthcare.

Collaborations

Some of her notable coworkers include Martin B Oleksiewicz and Lars Soegaard Nielsen, who have collaborated with her on various projects within the company.

Conclusion

Margit Haahr Hansen's contributions to biotechnology, particularly in the development of recombinant polyclonal antibodies, highlight her role as a leading inventor in her field. Her innovative patents are set to make a lasting impact on therapeutic methods and antibody technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…